Managing Cardiometabolic Risk

Publications

Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. Can J Cardiol 2006;22:913-27
By McPherson R, Frohlich J, Fodor G, Genest J, Canadian Cardiovascular Society

AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006;113:2363-72
By Smith SC, Allen J, Blair SN et al. 

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-52
By Grundy SM, Cleeman JI, Daniels SR et al.

Managing abnormal blood lipids: a collaborative approach. Circulation 2005;112:3184-209
By Fletcher B, Berra K, Ades P et al.

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004;110:227-39
By Grundy SM, Cleeman JI, Merz CN et al. 

Dyslipidemia management in adults with diabetes. Diabetes Care 2004;27:S68-71
By Haffner SM; American Diabetes Association

ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins. Stroke 2002;33:2337-41
By Pasternak RC, Smith SC, Bairey-Merz CN et al.

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97
By Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults